For example, it was demonstrated that NKG2A blockade combined with cancer vaccines had a bimodal effect on i.t. and systemic CD8+ T-cell responses, underscoring the potential of checkpoint modulation to enhance VSV-induced antitumor immunity further [34]. The gene discussed is CD8A; the disease is cancer.